Corbion Full Year 2024 Earnings: Beats Expectations

Corbion (AMS:CRBN) Full Year 2024 Results

Key Financial Results

• Revenue: €1.29b (up 1.9% from FY 2023).
• Net income: €45.9m (up 6.5% from FY 2023).
• Profit margin: 3.6% (up from 3.4% in FY 2023). The increase in margin was driven by higher revenue.
• EPS: €0.79 (up from €0.73 in FY 2023).

The end of cancer? These 15 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Corbion Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) also surpassed analyst estimates significantly.

The primary driver behind last 12 months revenue was the Functional Ingredients & Solutions segment contributing a total revenue of €997.9m (77% of total revenue). Notably, cost of sales worth €968.5m amounted to 75% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to €110.0m (40% of total expenses). Explore how CRBN's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Europe.

Performance of the market in the Netherlands.

The company's shares are down 3.0% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 2 warning signs for Corbion you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.